Cyclo Therapeutics (CYTH) News Today $0.77 +0.07 (+9.61%) Closing price 01/31/2025 03:57 PM EasternExtended Trading$0.77 0.00 (0.00%) As of 01/31/2025 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Cyclo Therapeutics (NASDAQ:CYTH) versus Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) Critical AnalysisJanuary 30 at 1:21 AM | americanbankingnews.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, CYTH, ALVR on Behalf of ShareholdersJanuary 24, 2025 | stockhouse.com$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger - CYTH, ALVR, WMPN, OMCJanuary 24, 2025 | markets.businessinsider.comSHAREHOLDER ALERT: The M&A Class Action Firm Continues Its Merger Investigation - AUB, CYTH, PDCO, SKGRDecember 20, 2024 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LTRPA, LTRPB, CYTH, SKGR on Behalf of ShareholdersDecember 20, 2024 | prnewswire.comRafael Holdings, Inc.: Rafael Holdings Reports First Quarter Fiscal 2025 Financial ResultsDecember 11, 2024 | finanznachrichten.deNiemann-Pick Disease Pipeline Market Research 2024: Comprehensive Insights about 12+ Drugs Featuring Cyclo Therapeutics, Azafaros, IntraBioNovember 21, 2024 | globenewswire.comCyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 15, 2024 | finance.yahoo.comPacira BioSciences Appoints Shawn Cross As CFOOctober 21, 2024 | markets.businessinsider.comMaxim Group Downgrades Cyclo Therapeutics (CYTH)August 29, 2024 | msn.comCYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTHAugust 27, 2024 | businesswire.comHC Wainwright & Co. Downgrades Cyclo Therapeutics (CYTH)August 24, 2024 | msn.comShareholder Alert: Ademi LLP investigates whether Cyclo Therapeutics, Inc. has obtained a Fair Price for its Public ShareholdersAugust 23, 2024 | prnewswire.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Cyclo Therapeutics, Inc. MergerAugust 22, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cyclo Therapeutics, Inc. - CYTHAugust 22, 2024 | prnewswire.comSector Update: Health Care Stocks Flat to Higher Premarket ThursdayAugust 22, 2024 | nasdaq.comRafael Holdings And Cyclo Therapeutics Agree To MergeAugust 22, 2024 | markets.businessinsider.comCyclo Therapeutics falls after merger agreement with Rafael HoldingsAugust 22, 2024 | msn.comCyclo Therapeutics Second Quarter 2024 Earnings: Misses ExpectationsAugust 18, 2024 | finance.yahoo.comOptimistic Buy Rating for Cyclo Therapeutics Amidst Promising Clinical Trials and Financial ProspectsAugust 17, 2024 | markets.businessinsider.comCyclo Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 15, 2024 | finance.yahoo.comCyclo Therapeutics Inc (CYTH)July 31, 2024 | investing.comCyclo Therapeutics secures European patent for Alzheimer's treatmentJuly 31, 2024 | investing.comCyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024June 25, 2024 | businesswire.comCyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1May 30, 2024 | businesswire.comCYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q1 2024May 16, 2024 | investorplace.comCyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 16, 2024 | businesswire.comHC Wainwright & Co. Initiates Coverage of Cyclo Therapeutics (CYTH) with Buy RecommendationMay 2, 2024 | msn.comAscendiant Capital Initiates Coverage of Cyclo Therapeutics (CYTH) with Buy RecommendationApril 23, 2024 | nasdaq.comAnalysts Offer Insights on Healthcare Companies: Cyclo Therapeutics (CYTH), CytomX Therapeutics (CTMX) and Pacific Biosciences (PACB)April 22, 2024 | markets.businessinsider.comPleasing Signs As A Number Of Insiders Buy Cyclo Therapeutics StockApril 10, 2024 | finance.yahoo.comCYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023March 19, 2024 | investorplace.comCyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateMarch 18, 2024 | businesswire.comCyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s DiseaseMarch 14, 2024 | finance.yahoo.comCyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer's DiseaseMarch 14, 2024 | businesswire.comCyclo Therapeutics, Inc. (CYTH)February 2, 2024 | finance.yahoo.comCyclo Therapeutics Gets Notice Of Allowance For Patent Regarding Treatment Of Alzheimer's DiseaseJanuary 29, 2024 | markets.businessinsider.comCyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark OfficeJanuary 29, 2024 | finance.yahoo.comCyclo Therapeutics Inc CYTHJanuary 3, 2024 | morningstar.comCytosorbents, Cyclo Therapeutics among healthcare moversDecember 28, 2023 | msn.comCyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1December 18, 2023 | finance.yahoo.comRafael Holdings Reports First Quarter Fiscal 2024 Financial ResultsDecember 14, 2023 | finance.yahoo.comAPPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied ...November 29, 2023 | businesswire.comCyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024November 21, 2023 | finance.yahoo.comCyclo Therapeutics reports Q3 resultsNovember 15, 2023 | msn.comCyclo Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 15, 2023 | finance.yahoo.comWISH, REAL and PIXY among mid-day moversNovember 10, 2023 | seekingalpha.comSeveral Insiders Invested In Cyclo Therapeutics Flagging Positive NewsNovember 2, 2023 | finance.yahoo.comRafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial ResultsOctober 30, 2023 | finance.yahoo.comCyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 MillionOctober 23, 2023 | finance.yahoo.com Get Cyclo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTH and its competitors with MarketBeat's FREE daily newsletter. Email Address CYTH Media Mentions By Week CYTH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYTH News Sentiment▼0.580.69▲Average Medical News Sentiment CYTH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYTH Articles This Week▼20▲CYTH Articles Average Week Get Cyclo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TARA News TNYA News ORMP News IMUX News ANIX News SCLX News IMAB News ME News CUE News INZY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYTH) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
